Latest News
Broadcom stock costs a lot, and may be worth the price.
Via The Motley Fool · June 6, 2025
Broadcom reported second-quarter financial results on Thursday after the market closed.
Via Benzinga · June 6, 2025
Alibaba releases open-source AI models in response to rising demand. Its new series supports 100+ languages and improves training and efficiency.
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
AI demand is aiding the energy sector, particularly benefiting independent power producers like Constellation Energy, Vistra, and NRG Energy.
Via Benzinga · June 6, 2025

GBP/JPY rises above the 20-day Simple Moving Average, providing support at 194.21.
Via Talk Markets · June 6, 2025

Via Benzinga · June 6, 2025

Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025

Since June 2024, interest rates have trended down from a two-decade high, yet remain above the historically low levels seen during the pandemic.
Via Talk Markets · June 6, 2025
The BLS reported that in May, the worst case scenario was averted, with the US adding a modest 139K, which, while below last month's print, was above the median consensus of 126K, and well inside the estimated range of 75K to 190K.
Via Talk Markets · June 6, 2025
Conagra Brands agreed to sell its Van de Kamp's and Mrs. Paul's frozen seafood brands to High Liner Foods for $55 million in cash.
Via Benzinga · June 6, 2025
Petco's stock plummeted after the company reported weaker-than-expected sales and a cautious outlook. Lingering concerns over weak consumer demand and competition drove the shares sharply lower.
Via Benzinga · June 6, 2025
Fidelity Investments launches FFUT, a managed futures ETF to diversify portfolios and protect against market volatility.
Via Benzinga · June 6, 2025
Tesla’s shares led gains among the Magnificent 7 stocks following a steep sell-off on Thursday amid CEO Elon Musk’s public clash with President Donald Trump.
Via Stocktwits · June 6, 2025
President Donald Trump's sweeping executive order overhauling U.S. election procedures faces federal court challenges from 19 Democratic state attorneys general who argue the directive violates constitutional separation of powers and infringes on states' election authority.
Via Benzinga · June 6, 2025
Via Stocktwits · June 6, 2025
U.S. Bancorp is one of the largest regional banks in the US, with assets of around $680 billion.
Via Talk Markets · June 6, 2025
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
A respectable jobs market in May with firm employment growth and stable unemployment, but the risks are skewed toward more weakness in coming months.
Via Talk Markets · June 6, 2025
The U.S. President further noted that a rate reduction by the Fed would greatly help in managing the debt that is coming due.
Via Stocktwits · June 6, 2025
ICE stock is currently in its 8th Phase of the 18-Phase Adhishthana Cycle. While the structure appears strong a pullback may occur.
Via Benzinga · June 6, 2025
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via Chartmill · June 6, 2025
FuelCell Energy (FCEL) reports mixed results for Q2 fiscal 2025, announces global restructuring plan to cut costs and align production with demand.
Via Benzinga · June 6, 2025
Via Benzinga · June 6, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · June 6, 2025
The $1.2 million contract involves deploying 150 AI-powered traffic monitoring units in a Sun Belt state, replacing outdated systems with safer alternatives.
Via Stocktwits · June 6, 2025

Via Benzinga · June 6, 2025

Disney theme parks have been the growth engine for tourism, job creation, and tax revenue in Southern California and Central Florida.
Via Benzinga · June 6, 2025

Via Benzinga · June 6, 2025

Arvinas and Pfizer submit NDA to FDA for vepdegestrant after Phase 3 data shows efficacy in ESR1-mutated ER+/HER2- breast cancer patients
Via Benzinga · June 6, 2025